Benzonitrile,4-(4,5-dihydro-1H-imidazol-2-yl)- structure
|
Common Name | Benzonitrile,4-(4,5-dihydro-1H-imidazol-2-yl)- | ||
---|---|---|---|---|
CAS Number | 850786-33-3 | Molecular Weight | 171.20 | |
Density | 1.2±0.1 g/cm3 | Boiling Point | 327.7±44.0 °C at 760 mmHg | |
Molecular Formula | C10H9N3 | Melting Point | N/A | |
MSDS | N/A | Flash Point | 152.0±28.4 °C |
Use of Benzonitrile,4-(4,5-dihydro-1H-imidazol-2-yl)-SARS-CoV-2-IN-59 (compound E07), an imidazoline derivative, is a non-peptide small molecule inhibitor of SARS-CoV-2 that targets the main protease (Mpro) of the coronavirus. SARS-CoV-2-IN-59 has a strong interaction with residues on Mpro (Met 165, Gln 166, Met 165, His 41, Gln 189)[1]. |
Name | 4-(4,5-Dihydro-1H-imidazol-2-yl)benzonitrile |
---|---|
Synonym | More Synonyms |
Description | SARS-CoV-2-IN-59 (compound E07), an imidazoline derivative, is a non-peptide small molecule inhibitor of SARS-CoV-2 that targets the main protease (Mpro) of the coronavirus. SARS-CoV-2-IN-59 has a strong interaction with residues on Mpro (Met 165, Gln 166, Met 165, His 41, Gln 189)[1]. |
---|---|
Related Catalog | |
Target |
SARS-CoV-2[1] |
References |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 327.7±44.0 °C at 760 mmHg |
Molecular Formula | C10H9N3 |
Molecular Weight | 171.20 |
Flash Point | 152.0±28.4 °C |
Exact Mass | 171.079651 |
LogP | 0.00 |
Vapour Pressure | 0.0±0.7 mmHg at 25°C |
Index of Refraction | 1.642 |
MFCD16877945 |
4-(4,5-Dihydro-1H-imidazol-2-yl)benzonitrile |
Benzonitrile, 4-(4,5-dihydro-1H-imidazol-2-yl)- |